<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene K417N;E484K literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.K417N;E484K</span> literature reference collection</h1>
<div class="effect_section"><h2 id="pharmaceutical_effectiveness">Pharmaceutical effectiveness</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Bamlanivimab (LY-CoV555) lost ~32x binding against this double mutation.<br/> COR-101 lost ~160x binding against this double mutation.<br/>Casirivimab lost ~16x binding against this double mutation. Estesevimab lost ~32x binding against this double mutation.<br/>Regdanvimab lost ~4x binding against this double mutation. Tixagevimab lost ~12x binding against this double mutation.<br/> (<a href="https://doi.org/10.1101/2021.04.27.440939" class="lit_link">Engelhart et al. (2021)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
